New Public-Private Partnership Will Halve the Cost of Long-Lasting Contraceptive Implant for World's Poorest

This week, MSD, the Bill & Melinda Gates Foundation, and other global health leaders took a step toward fulfilling commitments made at the London Summit on Family Planning by announcing a new public-private partnership to increase access to long-acting contraceptive implants in some of the world’s poorest countries.

MSD has generously agreed to halve the cost of IMPLANON and its next generation implant, IMPLANON NXT, for supply through reproductive health projects in select developing countries throughout the next six years. IMPLANON is a single-rod, long-acting, and reversible contraceptive implant that offers women three years of pregnancy protection. The implants are pre-packaged and fully sterilized, both advantageous features for working in settings with limited health care infrastructure.

The announcement comes just weeks after a similar agreement between Bayer HealthCare AG and the Bill & Melinda Gates Foundation regarding the long-acting implant Jadelle. Pathfinder is thrilled to see this continued emphasis on commitments made in London last summer, particularly as it pertains to improving access to reproductive health services for the world’s 222 million women who currently want, but lack access to modern methods of contraception. It is our hope that these innovative new partnerships will inspire additional support for reproductive health care and services that contribute to stronger, healthier women and communities worldwide.

Media Contact

For more information, please contact communications@pathfinder.org or call 617.972.1291.

Related News

43 percent of pregnancies unintended in Sindh, seminar told

Pathfinder's Tauseef Ahmed, Country Representative in Pakistan, discusses the difficulties the country faces due to its high population.

Photo Journal: There’s an app for that

Kenya’s mobile incentive program improves the health of mothers and children, while offering secure and reliable payment to frontline health workers.

Scroll to top